[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"health-studies-list:{\"conditionNormalized\":\"granulomatosis-with-polyangiitis-gpa\",\"overallStatus\":[\"RECRUITING\",\"AVAILABLE\",\"NOT_YET_RECRUITING\"],\"orderBy\":\"LastUpdateSubmitDate:desc\",\"size\":25,\"offset\":0}":3,"health-study-condition:granulomatosis-with-polyangiitis-gpa":29},{"pageToken":4,"total":5,"offset":6,"count":5,"results":7},null,3,0,[8,56,89],{"id":9,"slug":10,"hasResults":11,"nctId":12,"briefTitle":13,"officialTitle":13,"acronym":14,"eligibilityCriteria":15,"healthyVolunteers":11,"sex":16,"minAge":17,"maxAge":4,"enrollmentInfo":18,"targetDuration":4,"studyType":21,"phases":4,"briefSummary":22,"conditions":23,"keywords":34,"overallStatus":43,"whyStopped":4,"lastUpdateSubmitDate":44,"lastUpdatePostDateStruct":45,"startDateStruct":48,"completionDateStruct":50,"leadSponsor":52,"locationsCount":55},"100286105","clinical-transcriptomics-in-systemic-vasculitis-cutis-100286105",false,"NCT03004326","Clinical Transcriptomics in Systemic Vasculitis (CUTIS)","CUTIS","Inclusion Criteria:\n\n* Have a cutaneous lesion (purpuric macules, palpable purpura, retiform purpura, nodules, ulcers, or urticarial) believed to be related to active vasculitis\n* Have a suspected or confirmed diagnosis of:\n\n  * Cryoglobulinemic vasculitis (CV)\n  * Drug-induced vasculitis\n  * Eosinophilic granulomatosis with polyangiitis (EGPA)\n  * IgA vasculitis\n  * Isolated cutaneous vasculitis\n  * Granulomatosis with polyangiitis (GPA)\n  * Microscopic polyangiitis (MPA)\n  * Polyarteritis nodosa (PAN)\n  * Urticarial vasculitis\n* Be willing and able to provide written informed consent (or assent for those under\n\nExclusion Criteria:\n\n* You are less than five years old\n* Considered not to be a candidate for a biopsy or have a higher risk of developing an infection, bleeding, etc., from the biopsy, or a doctor believes that the risks for you participating in this study do not outweigh the potential benefit of learning information from your biopsy\n* You have a neutrophil count (type of white blood cell) less than 1500\u002Fmm3, platelet count less than 50,000\u002Fmm3, or a hemoglobin less than 7 g\u002FdL\n* You have an uncontrolled disease that could prevent you from completing the study procedures\n* You have an active infection at or near the potential biopsy site, have poor circulation, or have bony prominence or other structure that would increase your risk of complications if you participated in this study\n* You are pregnant or nursing\n* You are not able to provide informed consent","ALL","5 Years",{"count":19,"type":20},50,"ESTIMATED","OBSERVATIONAL","Multi-center observational study to evaluate the histopathology and transcriptome of cutaneous lesions in patients with several different types of vasculitis.",[24,25,26,27,28,29,30,31,32,33],"Cryoglobulinemic Vasculitis (CV)","Drug-induced Vasculitis","Eosinophilic Granulomatosis With Polyangiitis (EGPA)","IgA Vasculitis","Isolated Cutaneous Vasculitis","Granulomatosis With Polyangiitis (GPA)","Microscopic Polyangiitis (MPA)","Polyarteritis Nodosa (PAN)","Urticarial Vasculitis","Vasculitis",[35,36,37,38,39,40,41,42],"DIV","CSS","EGPA","HSP","GPA","MPA","PAN","Wegeners","RECRUITING","2026-01-21",{"date":46,"type":47},"2026-01-22","ACTUAL",{"date":49,"type":47},"2017-01",{"date":51,"type":20},"2028-12",{"name":53,"class":54},"Peter Merkel","OTHER",10,{"id":57,"slug":58,"hasResults":11,"nctId":59,"briefTitle":60,"officialTitle":61,"acronym":62,"eligibilityCriteria":63,"healthyVolunteers":11,"sex":64,"minAge":65,"maxAge":66,"enrollmentInfo":67,"targetDuration":69,"studyType":21,"phases":4,"briefSummary":70,"conditions":71,"keywords":4,"overallStatus":43,"whyStopped":4,"lastUpdateSubmitDate":44,"lastUpdatePostDateStruct":80,"startDateStruct":82,"completionDateStruct":84,"leadSponsor":86,"locationsCount":88},"100254637","vasculitis-pregnancy-registry-100254637","NCT02593565","Vasculitis Pregnancy Registry","The Vasculitis Pregnancy Registry (V-PREG)","V-PREG","Inclusion Criteria:\n\n1. Women 18 years of age or older with one of the following diseases may take part in the study:\n\n   * Behçet's disease;\n   * Central nervous system (CNS) vasculitis;\n   * Cryoglobulinemic vasculitis (Cryoglobulinemia);\n   * Eosinophilic granulomatosis with polyangiitis (also called Churg-Strauss Syndrome);\n   * Giant Cell (Temporal) Arteritis (GCA);\n   * Granulomatosis with polyangiitis (also called Wegener's);\n   * IgA vasculitis (Henoch-Schoenlein purpura);\n   * Microscopic polyangiitis (MPA);\n   * Polyarteritis nodosa (PAN);\n   * Takayasu's arteritis (TAK);\n   * Urticarial vasculitis;\n   * Other\u002FSuspected Diagnosis.\n2. Women must be pregnant (self-report) at the time of enrollment into the registry.\n\nExclusion Criteria:\n\n1. Non-English speaking, with the exception of people who speak Spanish, Portuguese, Italian, or Turkish.\n2. Unable to provide consent.","FEMALE","18 Years","50 Years",{"count":68,"type":20},100,"12 Months","The purpose of this study is to learn about the experience of women with vasculitis who become pregnant. In particular, the study will consist of several online surveys to assess\n\n1. each woman's vasculitis severity and pregnancy-related experiences, and\n2. pregnancy outcomes.",[33,72,73,74,26,75,29,76,27,77,30,31,78,32,79],"Behcet's Disease","CNS Vasculitis","Cryoglobulinemic Vasculitis","Churg-Strauss Syndrome (CSS)","Wegener's Granulomatosis","Henoch-Schoenlein Purpura (HSP)","Takayasu Arteritis (TAK)","Systemic Vasculitis",{"date":81,"type":47},"2026-01-23",{"date":83,"type":4},"2015-11",{"date":85,"type":20},"2027-12",{"name":87,"class":54},"University of Pennsylvania",1,{"id":90,"slug":91,"hasResults":11,"nctId":92,"briefTitle":93,"officialTitle":94,"acronym":4,"eligibilityCriteria":95,"healthyVolunteers":11,"sex":16,"minAge":4,"maxAge":4,"enrollmentInfo":96,"targetDuration":98,"studyType":21,"phases":4,"briefSummary":99,"conditions":100,"keywords":4,"overallStatus":43,"whyStopped":4,"lastUpdateSubmitDate":101,"lastUpdatePostDateStruct":102,"startDateStruct":104,"completionDateStruct":106,"leadSponsor":108,"locationsCount":88},"100574360","special-drug-use-results-survey-for-long-term-useavacopan-100574360","NCT06758271","Special Drug Use-results Survey for Long-term Use（Avacopan）","Special Drug Use-results Survey for Long-term Use","Inclusion Criteria:\n\n* Patients with granulomatosis with polyangiitis or microscopic polyangiitis who are treatment with avacopan",{"count":97,"type":20},250,"2 Years","The purpose of this survey is evaluating the safety and efficacy of long-term administration of avacopan for Japanese patients with microscopic polyangiitis or granulomatosis with polyangiitis under actual conditions of use.",[30,29],"2025-01-15",{"date":103,"type":47},"2025-01-17",{"date":105,"type":47},"2022-07-29",{"date":107,"type":20},"2028-05-31",{"name":109,"class":110},"Kissei Pharmaceutical Co., Ltd.","INDUSTRY"]